期刊文献+

甘氨酸茶碱钠缓释片体外释放与体内吸收的相关性研究 被引量:2

Sodium Theophylline Glycinate Sustained Release Tablets:The Correlation Between In vitro-release and In vitro-alsorption
暂未订购
导出
摘要 本文采用高效液相色谱法对12名男性健康志愿者单剂量口服含100mg无水茶碱的甘氨酸茶碱钠缓释片后血浆中茶碱的浓度进行检测并利用Waguer-Nelson法计算吸收百分率。对体内吸收百分率与体外释放百分率进行相关性研究。结果表明,当采用以浆法,水为溶出介质,转速为100r·min-1,本品体外药物释放与体内药物吸收具有较好的相关性,回归方程为:Y=0.89+1.12x,r=0.9906(n=6),因此,可以通过控制本品在体外的释放,达到控制体内药物吸收的目的。 In vitro and in vivo correlation of sodium theophylline glycinate (STG) sustainedrelease tabletS was investigated in this test. Plasma concentrations of theophylline in 12 healthymale volunteers were detendned by high performance liquid chromatography after single oraladministraion of STG sustained release tablets (100mg on the basis of an hydrous theophylline).In vivo absorption percentages of theophylline were calculated by Wagner-Nelson method.Invitro drug release profiles were determined in 900ml of water by paddle method at the spead of50r·min-1 and 100 r·min-1, respectively. The results showed that better IVIVC exist whendissolution proceeded in 900ml of water by paddle method at the speed of 100r·min-1. The invitro and in vivo correlation equation is Y=0.89+1.12×(r=0.9906, n=6). In vitro dissolutiontest under the given conditions could be used as the indication of in vivo absorption of STGsustained release tablets.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2000年第3期217-219,共3页 The Chinese Journal of Clinical Pharmacology
关键词 体外释放 体内吸收 甘氨酸茶碱钠 缓释片 高效液相色谱法 血药浓度 sodium theophyuine glycinate sustained release tablets in vitro in vivo correlation
  • 相关文献

参考文献1

  • 1何权流瀛,国外医学.呼吸系统疾仓册,1995年,15卷,76页

同被引文献17

  • 1张继稳,钟大放,毕殿洲.单室模型药物血管外给药零级、一级释放药物动力学[J].中国药理学通报,2005,21(2):245-248. 被引量:11
  • 2Wagner JG,Nelson E.Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug[J].J Pharm Sci,1964 ;53:1392.
  • 3中华人民共和国药典委员会.中华人民共和国药典.缓释、控释制剂指导原则[M].北京:化学工业出版社,2000(附录ⅩⅨ D):
  • 4USP-NF.In vitro-in vivo Correlations[M].Rockville:The United States Pharmacopoeial Convention Inc,2002:2163.
  • 5Dighe SV.Development of dissolution tests for immediate release and modified release oral dosage forms[A].Blume HH,Midha KK.Bio-International 2,Bioavailability,Bioequivalence and Pharmacokinetic Studies[M].Stuttgart:Medpharm Scientific Publishers,1995:247 -255.
  • 6Skelly JP,Shiu GF.In vitro/in vivo correlations in biopharmaceutics:scientific and regulatory implications[J].Eur J Drug Metab Pharmacokinet,1993 ;18:121-129.
  • 7Zhang JW,Zhong DF,Wang CF.A novel method for evaluating in vivo drug release kinetics based on zero-order release pharmacokinetics and dose division[J].STP Pharm Sci,2002; 12:177-180.
  • 8张继稳,钟大放,毕殿洲.释放分割法体外评价释放特征符合Higuchi方程的缓释制剂药物动力学[J].沈阳药科大学学报,2001,18(5):324-326. 被引量:14
  • 9王小兵,黄世铭,廖静怡,徐永群,唐斯萍,卢文贯.氢氯噻嗪药物共晶的制备、表征及量化计算[J].江西师范大学学报(自然科学版),2015,39(3):240-245. 被引量:5
  • 10张亚琪,黄燕婷,高缘,张建军.黄芩素-烟酰胺共晶结晶过程的热力学研究[J].中国药科大学学报,2015,46(5):568-574. 被引量:6

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部